The year is 2032. Studying the Electoral College map, a Democratic presidential candidate can no longer plan to sweep New Hampshire, Minnesota and the “blue wall” battlegrounds of Michigan, ...

Get the latest on Avidity Biosciences' late-stage RNA drug pipeline, upcoming FDA filings, and market opportunities for rare muscle diseases.

Get the latest on Annexon’s trailblazing therapies for GBS and GA, regulatory milestones, and upcoming data readouts.